June 2014

Spectranetics Acquires AngioScore

United States - California

In June 2014, The Spectranetics Corporation acquired AngioScore Inc. in a $230 million cash purchase, along with contingent commercial and regulatory milestone payments. Our firm's corporate team represented Spectranetics in the deal. The transaction was funded with the proceeds from a $230 million public offering of convertible notes, with our firm advising on the offering.

AngioScore is a leading developer, manufacturer and marketer of cardiovascular specialty balloons based in Fremont, California. The acquisition enhanced Spectranetics' cardiovascular medical device product portfolio and expanded its market opportunities.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.